美国 · 交易所与实时行情 · Nasdaq
Calytrix Bio To Be Bought By Lilly In Up To $1.5 Bln Cash Deal
详细摘要
(RTTNews) - Calytrix Bio, Inc., a biotechnology company focused on myeloproliferative neoplasms or MPNs, announced Monday its definitive agreement to be acquired by drug major Eli…
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.nasdaq.com)


